Previous Page  18 / 208 Next Page
Information
Show Menu
Previous Page 18 / 208 Next Page
Page Background

Chapter 1

16

encountered with high parenteral protein intake (3 g/kg/day), raising concerns of an increased

insulin resistance

76

. High doses of parenteral glucose are associated with side-effects, as

lipogenesis and hyperglycaemia, which can safely be prevented by amounts of parenteral

glucose belowcurrent guidelines

77,78

.Therefore, it remains unclear whether insufficient nutrient

administration by the enteral route should be supplemented with parenteral nutrition.

The stable and recovery phase of critical illness

The stable phase

The stable phase of critical illness is represented by stabilisation or weaning of vital organ

support, whereas the different aspects of the stress response are not (completely) resolved.

In addition to persistent low peripheral hormone levels, this phase is also characterised by a

central suppression of the different endocrine axes (Fig. 1)

14

. In contrast to the target organ

resistance marking the acute phase, peripheral tissues respond to low T3 concentrations by

increase of local hormone availability and effects

79,80

. Despite increased effect of this anabolic

hormone, large amounts of protein continue to be wasted, whereas fat stores remain relatively

intact

81

. Plasma cytokine concentrations are substantially decreased, but immune cell function

remains affected, as shown by persistent alterations in glycoprotein expression. The duration

of this phase can range from days to weeks, depending on the age and diagnosis of the child

82

.

In mixed populations of critically ill children, levels of anabolic hormones such as T3, growth

hormone and (bioavailable) IGF-1 already increase during the first week of admission

36,83

.

Recovery of anabolism appears to be in concert with the resolution of inflammation, as shown

by the relation between T3 and C-reactive protein (CRP) levels

36

and between early metabolic

markers, such as triglycerides levels, and immunologic parameters such as acute phase CD64

+

expression on neutrophils

24

.

However, despite early normalisation of the catabolic counter-regulatory hormone levels,

other parameters of the neuro-endocrine, metabolic and immunologic stress response might

need more time to resolve.

The recovery phase

Clinical mobilisation of the child, that is no longer in need of vital organ support, together

with resolution of the stress response, marks the onset of the recovery phase. This final phase

may last weeks to months. Hormone levels gradually return to normal (Fig. 1). The body shifts

from catabolism to anabolism with protein synthesis exceeding protein breakdown, resulting

in positive nitrogen balance, tissue repair and (catch-up) growth. Restoration of mitochondrial

function is achieved with accelerated stimulation of mitochondrial protein (biogenesis)

84

.

However, in children with burns a persistent hypermetabolic state is known to delay anabolism

and growth

85

, and suppressed insulin receptor signalling can be detected up to 250 days

postburn

86

.